Products

Etaracizumab (TAB-025)

Recombinant monoclonal antibody to Human CD51+CD61. Etaracizumab (also known as etaratuzumab, MEDI-522, trade name Abegrin) is a humanized monoclonal antibody which is being investigated for the treatment of metastatic melanoma, prostate cancer, ovarian cancer and various other types of cancer.      

  • Datasheet

Specifications
Immunogen
The details of the immunogen for this antibody are not available.
Host
Mouse
Derivation
Humanized (from mouse)
Type
IgG1
Specificity
Tested positive against native human antigen
Species Reactivity
Human
Applications
Suitable for use in IP, IF, FuncS, FC, Neut, ELISA, ICC and most other immunological methods.
Trade name
abegrin
CAS NO.
892553-42-3
Generic Name
Etaracizumab
UNII
41W9MFI160
M.W.
144.3 kDa
Related Disease
Melanoma, metastatic
Target
Alternative Names
Etaracizumab; abegrin; 892553-42-3; MEDI-522; hLM609; Vitaxin; LM609; etaratuzumab

For lab research use only, not for diagnostic, therapeutic or any in vivo human use.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Send Inquiry Now!
Name:
* Phone:
* E-mail Address:
* Service & Products Interested:
Project Description:
* Verification Code:
Verification code

Contact Us to Order
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email:

Increase Efficiency to Accelerate Your Research & Discovery Process

Increase Efficiency to Accelerate Your Research & 
Discovery Process

Creative Biolabs is the leading custom service provider that has extensive experience in various antibody production and engineering fields. Our service portfolio includes mouse and rat monoclonal antibody production ...

Find out more >

USA

45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-381-2994
Fax: 1-631-207-8356

Europe

Tel: 44-207-097-1828
Email:
Follow us on:
        

Terms of Service-Privacy Policy     © 2007 - 2019 Creative-Biolabs All Rights Reserved